tiprankstipranks
Uscom Limited (AU:UCM)
ASX:UCM
Australian Market
Holding AU:UCM?
Track your performance easily

Uscom Limited (UCM) Share Price & Analysis

0 Followers

UCM Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

59.33%0.00%0.00%40.67%
59.33% Insiders
0.00% Other Institutional Investors
40.67% Public Companies and
Individual Investors

UCM FAQ

What was Uscom Limited’s price range in the past 12 months?
Uscom Limited lowest share price was <AU$0.01 and its highest was AU$0.13 in the past 12 months.
    What is Uscom Limited’s market cap?
    Currently, no data Available
    When is Uscom Limited’s upcoming earnings report date?
    Uscom Limited’s upcoming earnings report date is Feb 19, 2025 which is in 88 days.
      How were Uscom Limited’s earnings last quarter?
      Uscom Limited released its earnings results on Aug 28, 2024. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
        Is Uscom Limited overvalued?
        According to Wall Street analysts Uscom Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Uscom Limited pay dividends?
          Uscom Limited does not currently pay dividends.
          What is Uscom Limited’s EPS estimate?
          Uscom Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Uscom Limited have?
          Uscom Limited has 250,477,000 shares outstanding.
            What happened to Uscom Limited’s price movement after its last earnings report?
            Uscom Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 100%.
              Which hedge fund is a major shareholder of Uscom Limited?
              Currently, no hedge funds are holding shares in AU:UCM
              ---

              Uscom Limited Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -66.66%
              12-Months-Change

              Fundamentals

              Return on Equity
              -67.97%
              Trailing 12-Months
              Asset Growth
              -0.88%
              Trailing 12-Months

              Company Description

              Uscom Limited

              USCOM Ltd is engaged in the development, design, manufacture, and marketing of premium non-invasive cardiovascular and pulmonary medical devices. The company's geographical segment includes Australia, Asia, America, Europe, and Other regions. It generates maximum revenue from Asia. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, SPIROSONIC, a pulmonary function testing device based on multi-path ultrasound technology and the VENTITEST and VENTITEST-S ultrasonic ventilator calibration devices for optimising respiratory device performance.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Cyclopharm Limited
              Race Oncology Ltd.
              LBT Innovations Limited
              Resonance Health Ltd
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis